Chylomicron remnants regulate early growth response factor-1 in vascular smooth muscle cells

Life Sciences

Volumn 77, Issue 6, 2005, Pages 670-682

  Takahashi, Yuko ^a   Fujioka, Yoshio ^a   Takahashi, Tomosaburo ^a   Domoto, Koji ^a   Takahashi, Akihiro ^a   Taniguchi, Takahiro ^a   Ishikawa, Yuichi ^b   Yokoyama, Mitsuhiro ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KOBE UNIVERSITY   (Japan)

Author keywords

Chylomicron remnants; Early growth response factor 1 (Egr 1); Inflammation; Interferon (IFN ); Interleukin 2 (IL 2); Vascular smooth muscle cells

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CHYLOMICRON; EARLY GROWTH RESPONSE FACTOR 1; GAMMA INTERFERON; INTERLEUKIN 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; GENETIC TRANSCRIPTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; VASCULAR SMOOTH MUSCLE;

ANIMALS; CELLS, CULTURED; CHYLOMICRON REMNANTS; CHYLOMICRONS; DNA-BINDING PROTEINS; EARLY GROWTH RESPONSE PROTEIN 1; IMMEDIATE-EARLY PROTEINS; MUSCLE, SMOOTH, VASCULAR; RATS; TRANSCRIPTION FACTORS;

EID: 19444375188     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2005.01.012     Document Type: Article

References (45)

1. N. Akuzawa, M. Kurabayashi, Y. Ohyama, M. Arai, and R. Nagai Zinc finger transcription factor Egr-1 activates Flt-1 gene expression in THP-1 cells on induction for macrophage differentiation Arteriosclerosis Thrombosis and Vascular Biology 20 2000 377 384
2. K.I. Arai, F. Lee, A. Miyajima, S. Miyatake, N. Arai, and T. Yokota Cytokines: coordinators of immune and inflammatory responses Annual Review of Biochemistry 59 1990 783 836
3. ++/NFAT Blood 99 2002 199 206
4. + T-lymphocytes and their interleukin 2 receptor expression in vitro Biochemical Journal 330 1998 659 666
5. Z. Chen, S. Ishibashi, S. Perrey, J. Osuga, T. Gotoda, T. Kitamine, Y. Tamura, H. Okazaki, N. Yahagi, Y. Iizuka, F. Shionoiri, K. Ohashi, K. Harada, H. Shimano, R. Nagai, and N. Yamada Troglitazone inhibits atherosclerosis in apolipoprotein E-knock-out mice: pleiotropic effects on CD36 expression and HDL Arteriosclerosis Thrombosis and Vascular Biology 21 2001 372 377
6. A.D. Cooper Hepatic uptake of chylomicron remnants Journal of Lipid Research 38 1997 2173 2192
7. M.-Z. Cui, M.S. Penn, and G.M. Chisolm Native and oxidized low density lipoprotein induction of tissue factor gene expression in smooth muscle cells is mediated by both Egr-1 and Sp1 Journal of Biological Chemistry 274 1999 32795 32802
8. E.L. Decker, C. Skerka, and P.F. Zipfel The early growth response protein (EGR-1) regulates interleukin-2 transcription by synergistic interaction with the nuclear factor of activated T cells Journal of Biological Chemistry 273 1998 6923 6930
9. H. Doi, K. Kugiyama, H. Oka, S. Sugiyama, N. Ogata, S.I. Koide, S.I. Nakamura, and H. Yasue Remnant lipoproteins induce proatherothrombogenic molecules in endothelial cells through a redox-sensitive mechanism Circulation 102 2000 670 676
10. K. Domoto, T. Taniguchi, H. Takaishi, T. Takahashi, Y. Fujioka, A. Takahashi, Y. Ishikawa, and M. Yokoyama Chylomicron remnants induce monocyte chemoattractant protein-1 expression via p38 MAPK activation in vascular smooth muscle cells Atherosclerosis 171 2003 193 200
11. J.L. Ellsworth, A.D. Cooper, and F.B. Kraemer Evidence that chylomicron remnants and β-VLDL are transported by the same receptor pathway in J774 murine macrophage-derived cells Journal of Lipid Research 27 1986 1062 1072
12. J.L. Ellsworth, F.B. Kraemer, and A.D. Cooper Transport of β-very low density lipoproteins and chylomicron remnants by macrophages is mediated by the low density lipoprotein receptor pathway Journal of Biological Chemistry 262 1987 2316 2325
13. L.G. Fong, T.A. Fong, and A.D. Cooper Inhibition of lipopolysaccharide- induced interleukin-1β mRNA expression in mouse macrophages by oxidized low density lipoprotein Journal of Lipid Research 32 1991 1899 1910
14. J. Frostegard, A.K. Ulfgren, P. Nyberg, U. Hedin, J. Swedenborg, U. Andersson, and G.K. Hansson Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines Atherosclerosis 145 1999 33 43
15. Y. Fujioka, A.D. Cooper, and L.G. Fong Multiple processes are involved in the uptake of chylomicron remnants by mouse peritoneal macrophages Journal of Lipid Research 39 1998 2339 2349
16. H.N. Ginsberg Is hypertriglyceridemia a risk factor for atherogenic cardiovascular disease? A simple question with a complicated answer Annals of Internal Medicine 126 1997 912 914
17. S. Gupta, A.M. Pablo, X. Jiang, N. Wang, A.R. Tall, and C. Schindler IFN-γ potentiates atherosclerosis in ApoE knock-out mice Journal of Clinical Investigation 99 1997 2752 2761
18. G.K. Hansson, J. Holm, S. Nygren, and L. Jonasson Detection of activated T-lymphocytes in human atherosclerotic plaque The American Journal of Pathology 135 1989 169 175
19. J. Jain, C. Loh, and A. Rao Transcriptional regulation of the IL-2 gene Current Opinion in Immunology 7 1995 333 342
20. F. Karpe, and A. Hamsten Postprandial lipoprotein metabolism and atherosclerosis Current Opinion in Lipidology 6 1995 123 129
21. S. Kawasaki, T. Taniguchi, Y. Fujioka, A. Takahashi, T. Takahashi, K. Domoto, M. Taguchi, Y. Ishikawa, and M. Yokoyama Chylomicron remnant induced apoptosis in vascular endothelial cells Annals of the New York Academy of Sciences 902 2000 336 341
22. L. Kolarovic, and N.C. Fournier A comparison of extraction methods for the isolation of phospholipids from biological sources Annals of Biochemistry 156 1986 244 250
23. K. Kugiyama, H. Doi, T. Motoyama, H. Soejima, K. Misumi, H. Kawano, O. Nakagawa, M. Yoshiyama, H. Ogawa, T. Matsumura, S. Sugiyama, T. Nakano, K. Nakajima, and H. Yasue Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries Circulation 97 1998 2519 2526
24. P. Libby Inflammation in atherosclerosis Nature 420 2002 868 874
25. A. Loidl, R. Claus, E. Ingolic, H.-P. Deigner, and A. Hermetter Role of ceramide in activation of stress-associated MAP kinases by minimally modified LDL in vascular smooth muscle cells Biochimica et Biophysica Acta 1690 2004 150 158
26. N. Marx, B. Kehrle, K. Kohlhammer, M. Grüb, W. Koenig, V. Hombach, P. Libby, and J. Plutzky PPAR activators as anti-inflammatory mediators in human T lymphocytes. Implications for atherosclerosis and transplantation-associated arteriosclerosis Circulation Research 90 2002 703 710
27. A. Mazzone, S.D. Servi, M. Vezzoli, G. Fossati, I. Mazzucchelli, D. Gritti, E. Ottini, A. Mussini, and G. Specchia Plasma levels of interleukin 2, 6, 10 and phenotypic characterization of circulating T lymphocytes in ischemic heart disease Atherosclerosis 145 1999 369 374
28. T.A. McCaffrey, C. Fu, B. Du, S. Eksinar, K.C. Kent, H. Bush Jr., K. Kreiger, T. Rosengart, and M.I. Cybulsky Silverman ES, Collins T. High-level expression of Egr-1, and Egr-1- inducible genes in mouse and human atherosclerosis Journal of Clinical Investigation 105 2000 653 662
29. J.R. McNamara, P.K. Shah, K. Nakajima, L.A. Cupples, P.W. Wilson, J.M. Ordovas, and E.J. Schaffer Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study Atherosclerosis 154 2001 229 236
30. M. Morimoto, N. Kume, S. Miyamoto, Y. Ueno, H. Kataoka, M. Minami, K. Hayashida, N. Hashimoto, and T. Kita Lysophosphadylcholine induces early growth response factor-1 expression and activates the core promotor of PDGF-A chain in vascular endothelial cells Arteriosclerosis Thrombosis and Vascular Biology 21 2001 771 776
31. S. Morimoto, Y. Fujioka, H. Hosoai, T. Okumura, M. Masai, T. Sakoda, T. Tsujino, M. Ohyanagi, and T. Iwasaki The renin-angiotensin system is involved in production of plasminogen activator inhibitor type 1 by cultured endothelial cells in response to chylomicron remnants Hypertension Research 26 2003 315 323
32. T. Okumura, Y. Fujioka, S. Morimoto, S. Tsuboi, M. Masai, T. Tsujino, M. Ohyanagi, and T. Iwasaki Eicosapentaenoic acid improves endothelial function in hypertriglyceridemic subjects despite increased lipid oxidizability The American Journal of the Medical Sciences 324 2002 247 253
33. H. Ozaki, K. Ishii, H. Arai, N. Kume, and T. Kita Lysophosphatidylcholine activates mitogen-activated protein kinases by a tyrosine kinase-dependent pathway in bovine aortic endothelial cells Atherosclerosis 143 1999 261 266
34. S.D. Proctor, and J.C. Mamo Intimal retention of cholesterol derived from apolipoprotein B100- and apolipoprotein B48-containing lipoproteins in carotid arteries of Watanabe heritable hyperlipidemic rabbits Arteriosclerosis Thrombosis and Vascular Biology 23 2003 1595 1600
35. T.G. Redgrave Formation of cholesterol ester-rich particulate lipid during metabolism of chylomicrons Journal of Clinical Investigation 49 1970 465 471
36. R. Ross Atherosclerosis. An inflammatory disease The New England Journal of Medicine 340 1999 115 126
37. A. Sachinidis, Y. Ko, A. Wieczorek, B. Weisser, R. Locher, W. Vetter, and H. Vetter Lipoproteins induce expression of the early growth response gene-1 in vascular smooth muscle cells from rat Biochemical and Biophysical Research Communications 30 1993 794 799
38. E.S. Silverman, and T. Collins Pathways of Egr-1-mediated gene transcription in vascular biology The American Journal of Pathology 154 1999 665 670
39. E. Stoyanova, A. Tesch, V.W. Armstrong, and E. Wieland Enzymatically degraded low density lipoproteins are more potent inducers of egr-1 mRNA than oxidized or native low density lipoproteins Clinical Biochemistry 34 2001 483 490
40. P.E. Szmitko, C.-H. Wang, R.D. Weisel, J.R. de Almeida, T.J. Anderson, and S. Verma New markers of inflammation and endothelial cell activation. Part 1 Circulation 108 2003 1917 1923
41. C.E. Thomas, R.L. Jackson, D.F. Ohlweiler, and G. Ku Multiple lipid oxidation products in low density lipoproteins induce interleukin-1 beta release from human blood mononuclear cells Journal of Lipid Research 35 1994 417 427
42. M. Watanabe, Y. Ishikawa, T. Inatome, H. Fujiki, Y. Hosokawa, M. Wakabayashi, A. Takahashi, T. Taniguchi, and Y. Fujioka Immunohistochemical analysis of lipoprotein(a) deposition and inflammatory cells in coronary atherosclerosis Acta Histochemica Cytochemica 31 1998 49 54
43. X.Y. Yang, L.H. Wang, T. Chen, D.R. Hodge, J.H. Resau, L. DaSilva, and W.L. Farrar Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor g (PPARg) agonists. PPARg co-association with transcription factor NFAT Journal of Biological Chemistry 275 2000 4541 4544
44. K.C. Yu, and A.D. Cooper Postprandial lipoproteins and atherosclerosis Frontiers in Bioscience 6 2001 D332 D354
45. D. Zhao, J. Letterman, and B.M. Schreiber β-migrating very low density lipoprotein β(VLDL) activates smooth muscle cell mitogen-activated protein (MAP) kinase via G protein-coupled receptor-mediated transactivation of the epidermal growth factor (EGF) receptor Journal of Biological Chemistry 276 2001 30579 30588